128 related articles for article (PubMed ID: 12621452)
1. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.
Eliopoulos N; Al-Khaldi A; Crosato M; Lachapelle K; Galipeau J
Gene Ther; 2003 Mar; 10(6):478-89. PubMed ID: 12621452
[TBL] [Abstract][Full Text] [Related]
2. Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells.
Eliopoulos N; Lejeune L; Martineau D; Galipeau J
Mol Ther; 2004 Oct; 10(4):741-8. PubMed ID: 15451458
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.
Eliopoulos N; Gagnon RF; Francois M; Galipeau J
J Am Soc Nephrol; 2006 Jun; 17(6):1576-84. PubMed ID: 16672321
[TBL] [Abstract][Full Text] [Related]
4. Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy.
Eliopoulos N; Francois M; Boivin MN; Martineau D; Galipeau J
Cancer Res; 2008 Jun; 68(12):4810-8. PubMed ID: 18559528
[TBL] [Abstract][Full Text] [Related]
5. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.
Al-Khaldi A; Eliopoulos N; Martineau D; Lejeune L; Lachapelle K; Galipeau J
Gene Ther; 2003 Apr; 10(8):621-9. PubMed ID: 12692590
[TBL] [Abstract][Full Text] [Related]
6. Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice.
Daga A; Muraglia A; Quarto R; Cancedda R; Corte G
Gene Ther; 2002 Jul; 9(14):915-21. PubMed ID: 12085239
[TBL] [Abstract][Full Text] [Related]
7. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.
Copland IB; Jolicoeur EM; Gillis MA; Cuerquis J; Eliopoulos N; Annabi B; Calderone A; Tanguay JF; Ducharme A; Galipeau J
Cardiovasc Res; 2008 Aug; 79(3):405-15. PubMed ID: 18397963
[TBL] [Abstract][Full Text] [Related]
8. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
[TBL] [Abstract][Full Text] [Related]
9. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J
Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
[TBL] [Abstract][Full Text] [Related]
10. Nonviral gene delivery of erythropoietin by mesenchymal stromal cells.
Scheibe F; Gladow N; Mergenthaler P; Tucker AH; Meisel A; Prockop DJ; Priller J
Gene Ther; 2012 May; 19(5):550-60. PubMed ID: 21956691
[TBL] [Abstract][Full Text] [Related]
11. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice.
Zhang XS; Linkhart TA; Chen ST; Peng H; Wergedal JE; Guttierez GG; Sheng MH; Lau KH; Baylink DJ
J Gene Med; 2004 Jan; 6(1):4-15. PubMed ID: 14716672
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.
Gnecchi M; Melo LG
Methods Mol Biol; 2009; 482():281-94. PubMed ID: 19089363
[TBL] [Abstract][Full Text] [Related]
13. Organoids direct systemic expression of erythropoietin in mice.
Descamps V; Blumenfeld N; Perricaudet M; Beuzard Y; Kremer EJ
Gene Ther; 1995 Aug; 2(6):411-7. PubMed ID: 7584116
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia.
Kucic T; Copland IB; Cuerquis J; Coutu DL; Chalifour LE; Gagnon RF; Galipeau J
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F488-96. PubMed ID: 18524862
[TBL] [Abstract][Full Text] [Related]
16. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
18. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
19. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.
Dalle B; Payen E; Regulier E; Deglon N; Rouyer-Fessard P; Beuzard Y; Aebischer P
Gene Ther; 1999 Feb; 6(2):157-61. PubMed ID: 10435099
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors.
Sato H; Kuwashima N; Sakaida T; Hatano M; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Gambotto A; Pollack IF; Okada H
Cancer Gene Ther; 2005 Sep; 12(9):757-68. PubMed ID: 15832173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
